Ironwood Pharmaceuticals reported $2.34M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US $ 42.36M 5.55M
Ardelyx ARDX:US $ 0.75M 0.24M
Charles River Laboratories CRL:US $ 9.43M 2.11M
Coherus Biosciences CHRS:US $ 8.97M 3.18M
Emergent Biosolutions EBS:US $ 8.2M 0.8M
Esperion Therapeutics ESPR:US $ 14.06M 632K
Exact Sciences EXAS:US $ 4.48M 0.18M
Halozyme Therapeutics HALO:US $ 1.76M 0.3M
Intercept Pharmaceuticals ICPT:US $ 6.67M 8.64M
Ironwood Pharmaceuticals IRWD:US $ 2.34M 5.61M
Karyopharm Therapeutics KPTI:US $ 6.68M 1.26M
Lexicon Pharmaceuticals LXRX:US 110K 185K
Moderna Inc MRNA:US 6M 0
Myriad Genetics MYGN:US $ 0.9M 0.4M
Pacira Pharmaceuticals PCRX:US $ 10.25M 0.18M
Ptc Therapeutics PTCT:US $ 23.61M 1.01M
Puma Biotechnology PBYI:US $ 2.66M 0.05M
Sarepta Therapeutics SRPT:US $ 15.8M 0.25M
YTE INCY:US $ 0.68M 0.07M